Prostate cancer decisions — 2025

The Board denied service connection for various conditions, including prostate cancer and related disabilities, urinary incontinence, sleep apnea, hypertension, varicose veins, lumbar spine disability, hip arthritis, shoulder arthritis, ankle arthritis, knee strain, knee replacement, and hand arthritis. The only condition granted was a 10 percent rating for a fracture of the right proximal first metacarpal.

The Board granted service connection for prostate cancer, related to in-service exposures at Camp Lejeune.

The appeal for service connection for sleep apnea is dismissed as the benefit sought has been granted, making the case moot.

The Board denied service connection for the cause of the Veteran's death, finding that there was no evidence linking his prostate cancer with metastasis to his military service.

The Veteran is granted an effective date of April 25, 2014, for service connection for prostate cancer.

The Board remands the issue of service connection for prostate cancer to obtain an addendum opinion addressing the Veteran's toxic exposure risk activities.

The Board granted service connection for heart condition, hypertension, and residuals prostate cancer on a presumptive basis due to herbicide exposure under the PACT Act.

The Board granted service connection for prostate cancer, finding that the evidence supports a link between the Veteran's condition and toxic exposure during his military service at Camp Lejeune.

The Board denied service connection for chronic kidney disease, atrial fibrillation, hiatal hernia, COPD, and prostate cancer as a result of toxic exposure during the Veteran's military service.

The Board denied the veteran's claims for service connection, increased ratings, and earlier effective dates as there was no evidence to support a causal relationship between his current conditions and his active military service.

The Board granted service connection for prostate cancer, finding the evidence to be approximately balanced in favor of a causal relationship between the Veteran's prostate cancer and his military service at Camp Lejeune.

The Board denied service connection for various conditions and a TDIU, as the evidence did not support a finding that any of these disabilities were related to the Veteran's military service.

The Veteran's claim for special monthly compensation SMC(s) was denied as there is no reasonable possibility that any of his service-connected disabilities alone prevent substantially gainful employment.

The Board remands the claims for service connection for prostate cancer and an acquired psychiatric disorder due to new and relevant evidence being submitted.

The Board restored the Veteran's 100 percent disability rating for his service-connected prostate cancer, effective September 1, 2024.

The Board remands the claim for an increased rating greater than 40 percent from November 1, 2025, for prostate cancer to correct a pre-decisional duty to assist error.

The Board denied service connection for an acquired psychiatric disorder and a neck disability, while remanding claims for sinusitis, allergic rhinitis, prostate cancer, and benign prostate hypertrophy.

The Board denied service connection for dermatochalasis, meibomian gland dysfunction, and blepharitis. The claims for lumbosacral strain, left lower extremity radiculopathy (sciatic nerve), right shoulder tendinopathy, diabetes, and prostate cancer with urinary incontinence status-post prostatectomy were remanded.

The Board granted an initial disability evaluation of 40 percent for the Veteran's service-connected residuals of prostate cancer, status post prostatectomy.

The Board remands the claims for service connection for cryptogenic organizing pneumonia and prostate cancer to secure medical examinations and opinions.